Investment
Features
FeesSafety
Academy
More
Pluang+

Close Brothers beats cost forecasts, shares jump 13% on strong profit and growth outlook

Market News
29 Sep 2026
Proactive Investors
View Source
Bullish
Close Brothers beats cost forecasts, shares jump 13% on strong profit and growth outlook

Close Brothers Group PLC exceeded cost expectations, reporting adjusted operating expenses of £431 million versus the £448 million consensus, leading to higher profits and returns. Adjusted pre-tax profit was £120 million, surpassing the expected £111 million, and return on tangible equity rose to 5.5% against a forecast of 4.4%. Loan book growth accelerated to 4% in H2, with all divisions growing in the final quarter. Despite a slight increase in bad debt provisions, the company maintains strong capital ratios and has over £300 million headroom to support growth. Shore Capital reaffirmed a Buy rating with a 495p target price, expecting a significant re-rating and dividend resumption next year.

Close Brothers' cost performance and profit outlook provide context for financial sector trends. For readers following Financials-sector US stocks on Pluang, here is the market snapshot as of Sep 29, 2026 21:36 WIB: out of 85 priced stocks, 25 rose and 60 fell. Notable movers include MAIN at USD 56.22 with a +2.09% change and 73% sell order activity, NU at USD 12.48 with a +2.04% change and 90% buy order activity, and MARA at USD 12.34 with a +1.90% change. MAIN’s typical hold time is 89 days, the longest among these.

More News

Netflix stock rises after Deutsche Bank upgrades it amid mixed analyst opinions.

Netflix stock rises after Deutsche Bank upgrades it amid mixed analyst opinions.

Netflix shares rose 1.5% after Deutsche Bank upgraded the stock from Hold to Buy, citing recent price declines as a buying opportunity and stronger international trends. However, other analysts remain cautious, with Wells Fargo downgrading Netflix to...

Analyst Insights
Bullish
1 hour ago
Cytokinetics insiders, including CEO, sell significant shares amid stock trading below moving averages.

Cytokinetics insiders, including CEO, sell significant shares amid stock trading below moving averages.

Cytokinetics' CEO Robert I. Blum and other executives have recently sold large amounts of company stock, with Blum selling nearly 105,000 shares in total, including a major block under a pre-arranged trading plan. This insider selling occurs while th...

Market News
Bearish
1 hour ago
Carnival posts strong quarterly earnings with $1.92B net income amid rising cruise demand

Carnival posts strong quarterly earnings with $1.92B net income amid rising cruise demand

Carnival Corporation reported strong quarterly results with earnings per share of $1.43 and net income of $1.92 billion, surpassing analyst expectations. The company achieved record revenue of $8.44 billion, driven by growing consumer interest in cru...

Company Fundamentals
Bullish
1 hour ago
FactSet expects strong Q3 earnings with $4.35 EPS and $630M revenue, driven by AI demand and cost control.

FactSet expects strong Q3 earnings with $4.35 EPS and $630M revenue, driven by AI demand and cost control.

FactSet is set to report strong Q3 earnings with an expected EPS of $4.35 and revenue around $629.83 million, reflecting a 5.3% increase from last year. The company benefits from high demand for AI-related products, expanded client base, and effectiv...

Company Fundamentals
Bullish
1 hour ago
Jefferies posts strong Q3 with $1.09 EPS and $2.22B revenue, signaling 50% stock upside potential.

Jefferies posts strong Q3 with $1.09 EPS and $2.22B revenue, signaling 50% stock upside potential.

Jefferies Financial Group reported robust Q3 results with earnings per share of $1.09, beating analyst estimates and last year's $1.05. Revenue rose to $2.22 billion, driven by record banking revenue, surpassing expectations. Net earnings increased t...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App